Ke Li

Ke Li is currently serving as the Vice President of Vaccine Development and Technical Ops at Uvax Bio. With a Ph.D. in Organic Chemistry from New York University, Ke has extensive experience in the pharmaceutical industry, holding roles such as Director at Wilmington PharmaTech Company LLC and Associate Director at Zymergen. Prior to these positions, Ke worked as a Senior Research Investigator at DuPont and as a Research Associate at The Scripps Research Institute. Ke holds an MBA from the University of Delaware and a B.S. in Chemistry from Jilin University.